Human coronavirus NL63 replication is cyclophilin A-dependent and inhibited by non-immunosuppressive cyclosporine A-derivatives including Alisporivir (Q30317509)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Human coronavirus NL63 replication is cyclophilin A-dependent and inhibited by non-immunosuppressive cyclosporine A-derivatives including Alisporivir	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

17 June 2017

Human coronavirus NL63 replication is cyclophilin A-dependent and inhibited by non-immunosuppressive cyclosporine A-derivatives including Alisporivir (English)

1 reference

Europe PubMed Central

17 June 2017

human Coronavirus NL63

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Human coronavirus

object named as

Human coronavirus

1 reference

based on heuristic

inferred from title

Miroslav Malesevic

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24566223%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Christian Drosten

10

object named as

Christian Drosten

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24566223%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Thomas F Baumert

9

object named as

Thomas F Baumert

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24566223%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

8

object named as

Doreen Muth

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24566223%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

author name string

Javier Carbajo-Lozoya

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24566223%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Yue Ma-Lauer

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24566223%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Martin Theuerkorn

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24566223%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Viktoria Kahlert

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24566223%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Erik Prell

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24566223%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Brigitte von Brunn

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24566223%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Gunter Fischer

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24566223%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Albrecht von Brunn

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24566223%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

publication date

22 February 2014

1 reference

Europe PubMed Central

17 June 2017

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24566223%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

184

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24566223%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

44-53

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24566223%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Understanding Human Coronavirus HCoV-NL63~!2009-11-13~!2010-04-09~!2010-05-25~!

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.02.010

7 January 2021

Cyclophilin involvement in the replication of hepatitis C virus and other viruses.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.02.010

7 January 2021

Target cell cyclophilins facilitate human papillomavirus type 16 infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.02.010

7 January 2021

Targeting FKBP isoforms with small-molecule ligands

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.02.010

7 January 2021

Requirement for cyclophilin A for the replication of vesicular stomatitis virus New Jersey serotype

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.02.010

7 January 2021

Replication of human coronaviruses SARS-CoV, HCoV-NL63 and HCoV-229E is inhibited by the drug FK506.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.02.010

7 January 2021

Comparison of SARS and NL63 papain-like protease binding sites and binding site dynamics: inhibitor design implications

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.02.010

7 January 2021

Design, synthesis and crystallographic analysis of nitrile-based broad-spectrum peptidomimetic inhibitors for coronavirus 3C-like proteases

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.02.010

7 January 2021

Profiling of substrate specificities of 3C-like proteases from group 1, 2a, 2b, and 3 coronaviruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.02.010

7 January 2021

Debio-025 inhibits HIV-1 by interfering with an early event in the replication cycle

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.02.010

7 January 2021

Structural and biochemical characterization of the human cyclophilin family of peptidyl-prolyl isomerases

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.02.010

7 January 2021

Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.02.010

7 January 2021

Hosting the severe acute respiratory syndrome coronavirus: specific cell factors required for infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.02.010

7 January 2021

Cyclophilin inhibitors block arterivirus replication by interfering with viral RNA synthesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.02.010

7 January 2021

Cyclosporin A inhibits the replication of diverse coronaviruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.02.010

7 January 2021

The dominance of human coronavirus OC43 and NL63 infections in infants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.02.010

7 January 2021

Identification of a novel coronavirus in patients with severe acute respiratory syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.02.010

7 January 2021

Multiple roles of the capsid protein in the early steps of HIV-1 infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.02.010

7 January 2021

Cyclosporine Inhibits a Direct Interaction between Cyclophilins and Hepatitis C NS5A

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.02.010

7 January 2021

Cyclophilin and peptidyl-prolyl cis-trans isomerase are probably identical proteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.02.010

7 January 2021

Emerging treatments for hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.02.010

7 January 2021

Cyclophilins as modulators of viral replication

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.02.010

7 January 2021

Public health: Broad reception for coronavirus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.02.010

7 January 2021

Cyclophilin inhibitors: a novel class of promising host-targeting anti-HCV agents

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.02.010

7 January 2021

Profile of alisporivir and its potential in the treatment of hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.02.010

7 January 2021

Epidemiology and clinical presentations of the four human coronaviruses 229E, HKU1, NL63, and OC43 detected over 3 years using a novel multiplex real-time PCR method.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.02.010

7 January 2021

Plaque assay for human coronavirus NL63 using human colon carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.02.010

7 January 2021

Evidence supporting a zoonotic origin of human coronavirus strain NL63

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.02.010

7 January 2021

Involvement of cyclophilin B in the replication of Japanese encephalitis virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.02.010

7 January 2021

Essential Role of Cyclophilin A for Hepatitis C Virus Replication and Virus Production and Possible Link to Polyprotein Cleavage Kinetics

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.02.010

7 January 2021

Inhibition of human coronavirus 229E infection in human epithelial lung cells (L132) by chloroquine: involvement of p38 MAPK and ERK.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.02.010

7 January 2021

Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.02.010

7 January 2021

Bats are natural reservoirs of SARS-like coronaviruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.02.010

7 January 2021

Curing a viral infection by targeting the host: the example of cyclophilin inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.02.010

7 January 2021

Cyclophilin A interacts with influenza A virus M1 protein and impairs the early stage of the viral replication

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.02.010

7 January 2021

Nucleocapsid protein of SARS coronavirus tightly binds to human cyclophilin A.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.02.010

7 January 2021

Anti-inflammatory effects of extracellular cyclosporins are exclusively mediated by CD147.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.02.010

7 January 2021

Cyclophilin inhibitors for hepatitis C therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.02.010

7 January 2021

Novel polymeric inhibitors of HCoV-NL63.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.02.010

7 January 2021

Proteomics analysis unravels the functional repertoire of coronavirus nonstructural protein 3.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.02.010

7 January 2021

Coronaviruses post-SARS: update on replication and pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.02.010

7 January 2021

The SARS-coronavirus-host interactome: identification of cyclophilins as target for pan-coronavirus inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.02.010

7 January 2021

Fine tuning the inhibition profile of cyclosporine A by derivatization of the MeBmt residue

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.02.010

7 January 2021

Inhibition of human coronavirus NL63 infection at early stages of the replication cycle

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.02.010

7 January 2021

Cyclosporine Inhibits Flavivirus Replication through Blocking the Interaction between Host Cyclophilins and Viral NS5 Protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.02.010

7 January 2021

In vitro and in vivo comparative studies on immunosuppressive properties of cyclosporines A, C, D and metabolites M1, M17 and M21

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.02.010

7 January 2021

Effect of cyclosporin A and its metabolites and analogs on lipid peroxidation in rabbit renal microsomes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.02.010

7 January 2021

Differentiation between human coronaviruses NL63 and 229E using a novel double-antibody sandwich enzyme-linked immunosorbent assay based on specific monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.02.010

7 January 2021

Coronaviruses as DNA wannabes: a new model for the regulation of RNA virus replication fidelity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.02.010

7 January 2021

Human cellular restriction factors that target HIV-1 replication

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.02.010

7 January 2021

Digoxin up-regulates MDR1 in human colon carcinoma Caco-2 cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.02.010

7 January 2021

Suppression of feline coronavirus replication in vitro by cyclosporin A.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.02.010

7 January 2021

Zn(2+) inhibits coronavirus and arterivirus RNA polymerase activity in vitro and zinc ionophores block the replication of these viruses in cell culture

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.02.010

7 January 2021

Therapies for coronaviruses. Part 2: Inhibitors of intracellular life cycle.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.02.010

7 January 2021

Therapies for coronaviruses. Part I of II -- viral entry inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.02.010

7 January 2021

New cyclopeptides from Trichoderma polysporum (Link ex Pers.) Rifai: cyclosporins B, D and E (author's transl)

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.02.010

7 January 2021

Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.02.010

7 January 2021

Identification of a new human coronavirus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.02.010

7 January 2021

New HCV therapies on the horizon

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.02.010

7 January 2021

Chloroquine is a potent inhibitor of SARS coronavirus infection and spread

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.02.010

7 January 2021

Identification of host factors involved in coronavirus replication by quantitative proteomics analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.02.010

7 January 2021

Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.02.010

7 January 2021

Design of wide-spectrum inhibitors targeting coronavirus main proteases

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.02.010

7 January 2021

Cyclophilin A levels dictate infection efficiency of human immunodeficiency virus type 1 capsid escape mutants A92E and G94D.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.02.010

7 January 2021

Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.02.010

7 January 2021

Host-targeting agents for prevention and treatment of chronic hepatitis C - perspectives and challenges.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.02.010

7 January 2021

First infection by all four non-severe acute respiratory syndrome human coronaviruses takes place during childhood

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.02.010

7 January 2021

Peptide aldehyde inhibitors challenge the substrate specificity of the SARS-coronavirus main protease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.02.010

7 January 2021

Arrest all accessories--inhibition of hepatitis C virus by compounds that target host factors.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24566223

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Isolation and amino acid sequence of cyclophilin.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24566223

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cyclophilin inhibitors for the treatment of HCV infection.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24566223

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human coronaviruses: what do they cause?

1 reference

https://pubmed.ncbi.nlm.nih.gov/24566223

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Host factors in the replication of positive-strand RNA viruses

1 reference

https://pubmed.ncbi.nlm.nih.gov/24566223

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.VIRUSRES.2014.02.010

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24566223%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24566223%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24566223%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30317509&oldid=1898315724"